Get the Stockscreener App
27.23
1.04%
0.28
After Hours:
27.35
0.12
+0.44%
Hims Hers Health Inc stock is traded at $27.23, with a volume of 18.46M.
It is up +1.04% in the last 24 hours and down -21.50% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$26.95
Open:
$25.16
24h Volume:
18.46M
Relative Volume:
0.80
Market Cap:
$6.29B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
61.89
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
+1.57%
1M Performance:
-21.50%
6M Performance:
+26.30%
1Y Performance:
+119.42%
1-Day Range:
$25.16
$27.44
1-Week Range:
$25.16
$29.84
52-Week Range:
$11.20
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.23 | 6.29B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
170.63 | 396.58B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
63.84 | 152.89B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
95.50 | 77.04B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
142.81 | 47.28B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.39 | 43.57B | 15.46B | 1.03B | 1.34B | 0.53 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Bull of the Day: Hims & Hers Health (HIMS) - Yahoo Finance
Bull Of The Day: Hims & Hers Health (HIMS) - Barchart.com
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers - The Globe and Mail
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday - MSN
HIMS Stock: Ready To Bounce Back From $30? - Nasdaq
Economic Uncertainties Batter Trading in These 10 Firms - Insider Monkey
Long Term Trading Analysis for (HIMS) - news.stocktradersdaily.com
Hims & Hers health CFO sells $330,081 in stock - Investing.com Australia
BofA maintains Hims & Hers stock underperform with $22 target - Investing.com
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com - Investing.com UK
Hims & Hers health CFO sells $330,081 in stock By Investing.com - Investing.com India
Hims & Hers health chief legal officer sells $280,314 in stock - Investing.com Australia
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know - Yahoo Finance
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know | FinancialContent - FinancialContent
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - Yahoo Finance
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com - Investing.com India
Lobbying Update: $60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Nasdaq
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - The Joplin Globe
Is Hims Stock a Buy, Sell, or Hold? - theafricalogistics.com
8,601 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by O Shaughnessy Asset Management LLC - Defense World
InvestingPro’s Fair Value model predicted HIMS stock’s dramatic correction By Investing.com - Investing.com Canada
Truist Financial Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price - Defense World
Why Hims & Hers Stock Just Collapsed - AOL.com
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know - Yahoo
Jefferies raises Hims & Hers stock target to $25, maintains hold - Investing.com Canada
Hims & Hers, at a crossroads, wants to be the Netflix of healthcare - Sherwood News
Hims & Hers health COO Melissa Baird sells $910,687 in stock - Investing.com Canada
Here’s Cedar Grove Capital Management’s Take Away from Its Short Position Hims and Hers Health (HIMS) - MSN
Here’s Cedar Grove Capital Management’s Takeaway from Its Short Position Hims and Hers Health (HIMS) - Insider Monkey
Hims’ Weight Loss Expansion: Real Growth or Just Hype? - MarketBeat
Truist Cuts Price Target on Hims & Hers Health to $33 From $39, Keeps Hold Rating - MarketScreener
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know - Yahoo Finance
Here’s Why Hims & Hers Health (HIMS) is Growing Revenue And Profitability - Insider Monkey
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, and SoFi Technologies Experience Notable Market Activity - Insider Monkey
Sei Investments Co. Reduces Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - MSN
Hims & Hers health executive sells $63,402 in stock By Investing.com - Investing.com India
Hims & Hers health PAO Becklund Irene sells shares worth $63,402 - Investing.com Canada
Hims & Hers health executive sells $63,402 in stock - Investing.com
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock - Investing.com
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings - Yahoo Finance
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):